183 related articles for article (PubMed ID: 37967346)
1. A proteomic analysis of atrial fibrillation in a prospective longitudinal cohort (AGES-Reykjavik study).
Jonmundsson T; Steindorsdottir AE; Austin TR; Frick EA; Axelsson GT; Launer L; Psaty BM; Loureiro J; Orth AP; Aspelund T; Emilsson V; Floyd JS; Jennings L; Gudnason V; Gudmundsdottir V
Europace; 2023 Nov; 25(11):. PubMed ID: 37967346
[TBL] [Abstract][Full Text] [Related]
2. Risk prediction of atrial fibrillation in the community combining biomarkers and genetics.
Börschel CS; Ohlrogge AH; Geelhoed B; Niiranen T; Havulinna AS; Palosaari T; Jousilahti P; Rienstra M; van der Harst P; Blankenberg S; Zeller T; Salomaa V; Schnabel RB
Europace; 2021 May; 23(5):674-681. PubMed ID: 33458771
[TBL] [Abstract][Full Text] [Related]
3. Atrial ectopy and N-terminal pro-B-type natriuretic peptide as predictors of atrial fibrillation: a population-based cohort study.
Kumarathurai P; Mouridsen MR; Mattsson N; Larsen BS; Nielsen OW; Gerds TA; Sajadieh A
Europace; 2017 Mar; 19(3):364-370. PubMed ID: 27194537
[TBL] [Abstract][Full Text] [Related]
4. NT-proBNP is a powerful predictor for incident atrial fibrillation - Validation of a multimarker approach.
Svennberg E; Lindahl B; Berglund L; Eggers KM; Venge P; Zethelius B; Rosenqvist M; Lind L; Hijazi Z
Int J Cardiol; 2016 Nov; 223():74-81. PubMed ID: 27541645
[TBL] [Abstract][Full Text] [Related]
5. Assessment of causality of natriuretic peptides and atrial fibrillation and heart failure: a Mendelian randomization study in the FINRISK cohort.
Geelhoed B; Börschel CS; Niiranen T; Palosaari T; Havulinna AS; Fouodo CJK; Scheinhardt MO; Blankenberg S; Jousilahti P; Kuulasmaa K; Zeller T; Salomaa V; Schnabel RB
Europace; 2020 Oct; 22(10):1463-1469. PubMed ID: 32830215
[TBL] [Abstract][Full Text] [Related]
6. Exploration of pathophysiological pathways for incident atrial fibrillation using a multiplex proteomic chip.
Molvin J; Jujic A; Melander O; Pareek M; Råstam L; Lindblad U; Daka B; Leosdottir M; Nilsson P; Olsen M; Magnusson M
Open Heart; 2020; 7(1):e001190. PubMed ID: 32201587
[TBL] [Abstract][Full Text] [Related]
7. B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies.
Sinner MF; Stepas KA; Moser CB; Krijthe BP; Aspelund T; Sotoodehnia N; Fontes JD; Janssens AC; Kronmal RA; Magnani JW; Witteman JC; Chamberlain AM; Lubitz SA; Schnabel RB; Vasan RS; Wang TJ; Agarwal SK; McManus DD; Franco OH; Yin X; Larson MG; Burke GL; Launer LJ; Hofman A; Levy D; Gottdiener JS; Kääb S; Couper D; Harris TB; Astor BC; Ballantyne CM; Hoogeveen RC; Arai AE; Soliman EZ; Ellinor PT; Stricker BH; Gudnason V; Heckbert SR; Pencina MJ; Benjamin EJ; Alonso A
Europace; 2014 Oct; 16(10):1426-33. PubMed ID: 25037055
[TBL] [Abstract][Full Text] [Related]
8. Supraventricular arrhythmia, N-terminal pro-brain natriuretic peptide and troponin T concentration in relation to incidence of atrial fibrillation: a prospective cohort study.
Xiao J; Persson AP; Engström G; Johnson LSB
BMC Cardiovasc Disord; 2021 Mar; 21(1):134. PubMed ID: 33711943
[TBL] [Abstract][Full Text] [Related]
9. NT-proBNP as a marker for atrial fibrillation and heart failure in four observational outpatient trials.
Werhahn SM; Becker C; Mende M; Haarmann H; Nolte K; Laufs U; Zeynalova S; Löffler M; Dagres N; Husser D; Dörr M; Gross S; Felix SB; Petersmann A; Herrmann-Lingen C; Binder L; Scherer M; Hasenfuß G; Pieske B; Edelmann F; Wachter R
ESC Heart Fail; 2022 Feb; 9(1):100-109. PubMed ID: 34850596
[TBL] [Abstract][Full Text] [Related]
10. Joint Associations of Obesity and NT-proBNP With the Incidence of Atrial Fibrillation in the ARIC Study.
Almuwaqqat Z; O'Neal WT; Norby FL; Lutsey PL; Selvin E; Soliman EZ; Chen LY; Alonso A
J Am Heart Assoc; 2019 Oct; 8(19):e013294. PubMed ID: 31564186
[TBL] [Abstract][Full Text] [Related]
11. A polygenic risk score predicts atrial fibrillation in cardiovascular disease.
Marston NA; Garfinkel AC; Kamanu FK; Melloni GM; Roselli C; Jarolim P; Berg DD; Bhatt DL; Bonaca MP; Cannon CP; Giugliano RP; O'Donoghue ML; Raz I; Scirica BM; Braunwald E; Morrow DA; Ellinor PT; Lubitz SA; Sabatine MS; Ruff CT
Eur Heart J; 2023 Jan; 44(3):221-231. PubMed ID: 35980763
[TBL] [Abstract][Full Text] [Related]
12. Total NT-proBNP, a novel biomarker related to recurrent atrial fibrillation.
Staszewsky L; Meessen JMTA; Novelli D; Wienhues-Thelen UH; Disertori M; Maggioni AP; Masson S; Tognoni G; Franzosi MG; Lucci D; Latini R
BMC Cardiovasc Disord; 2021 Nov; 21(1):553. PubMed ID: 34798808
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of N-terminal pro-B-type natriuretic Peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation.
Roldán V; Vílchez JA; Manzano-Fernández S; Jover E; Gálvez J; Puche CM; Valdés M; Vicente V; Lip GY; Marín F
Stroke; 2014 Mar; 45(3):696-701. PubMed ID: 24519407
[TBL] [Abstract][Full Text] [Related]
14. Fragmented sinoatrial dynamics in the prediction of atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis.
Costa MD; Redline S; Soliman EZ; Goldberger AL; Heckbert SR
Am J Physiol Heart Circ Physiol; 2021 Jan; 320(1):H256-H271. PubMed ID: 32986961
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory proteomics profiling for prediction of incident atrial fibrillation.
Börschel CS; Ortega-Alonso A; Havulinna AS; Jousilahti P; Salmi M; Jalkanen S; Veikko S; Niiranen T; Schnabel RB
Heart; 2023 Jun; 109(13):1000-1006. PubMed ID: 36801832
[TBL] [Abstract][Full Text] [Related]
16. Proteomics and Risk of Atrial Fibrillation in Older Adults (From the Atherosclerosis Risk in Communities [ARIC] Study).
Norby FL; Tang W; Pankow JS; Lutsey PL; Alonso A; Steffen BT; Chen LY; Zhang M; Shippee ND; Ballantyne CM; Boerwinkle E; Coresh J; Folsom AR
Am J Cardiol; 2021 Dec; 161():42-50. PubMed ID: 34794617
[TBL] [Abstract][Full Text] [Related]
17. N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation).
Hijazi Z; Wallentin L; Siegbahn A; Andersson U; Christersson C; Ezekowitz J; Gersh BJ; Hanna M; Hohnloser S; Horowitz J; Huber K; Hylek EM; Lopes RD; McMurray JJ; Granger CB
J Am Coll Cardiol; 2013 Jun; 61(22):2274-84. PubMed ID: 23563134
[TBL] [Abstract][Full Text] [Related]
18. Change in Cardiac Biomarkers and Risk of Incident Heart Failure and Atrial Fibrillation in CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.
Bansal N; Zelnick LR; Soliman EZ; Anderson A; Christenson R; DeFilippi C; Deo R; Feldman HI; He J; Ky B; Kusek J; Lash J; Seliger S; Shafi T; Wolf M; Go AS; Shlipak MG;
Am J Kidney Dis; 2021 Jun; 77(6):907-919. PubMed ID: 33309861
[TBL] [Abstract][Full Text] [Related]
19. B-type natriuretic peptide over N-terminal pro-brain natriuretic peptide to predict incident atrial fibrillation after cryptogenic stroke.
Palà E; Pagola J; Juega J; Francisco-Pascual J; Bustamante A; Penalba A; Comas I; Rodriguez M; De Lera Alfonso M; Arenillas JF; de Torres R; Pérez-Sánchez S; Cabezas JA; Moniche F; González-Alujas T; Molina CA; Montaner J
Eur J Neurol; 2021 Feb; 28(2):540-547. PubMed ID: 33043545
[TBL] [Abstract][Full Text] [Related]
20. N-terminal pro-brain natriuretic peptide levels had an independent and added ability in the evaluation of all-cause mortality in older Chinese patients with atrial fibrillation.
Fu S; Jiao J; Guo Y; Zhu B; Luo L
BMC Geriatr; 2019 Feb; 19(1):56. PubMed ID: 30819103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
